Mutations within exons 12–15 of SF3B1, encoding the C-terminal portion of the protein, have been described in 20% of uveal melanoma, 19% of CLL and 1.8% of breast cancers [20, 22, 30]. Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.